Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the significance of bone disease in cancer in general and in multiple myeloma in particular
- Discuss the risks and benefits of intravenous bisphosphonates for the treatment of bone lesions in multiple myeloma
- Describe the rationale for targeting RANK/RANKL to treat bone loss in cancer
CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.